` INCR (InterCure Ltd) vs S&P 500 Comparison - Alpha Spread

I
INCR
vs
S&P 500

Over the past 12 months, INCR has underperformed S&P 500, delivering a return of -50% compared to the S&P 500's +18% growth.

Stocks Performance
INCR vs S&P 500

Loading
INCR
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
INCR vs S&P 500

Loading
INCR
S&P 500
Difference
www.alphaspread.com

Performance By Year
INCR vs S&P 500

Loading
INCR
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
InterCure Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

InterCure Ltd
Glance View

Market Cap
36.6m USD
Industry
Pharmaceuticals

InterCure Ltd. engages in the business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

INCR Intrinsic Value
5.3121 USD
Undervaluation 85%
Intrinsic Value
Price
I
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett